Adhesion molecules and H1-antihistamines

Clinical and Experimental Allergy, Supplement

Volumn 27, Issue 2, 1997, Pages 19-27

  Canonica, G W ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CETIRIZINE; CYCLOSPORIN A; DEFLAZACORT; EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON; HISTAMINE H1 RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; CHEMOTAXIS; CONFERENCE PAPER; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; IMMUNOREGULATION; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; T LYMPHOCYTE ACTIVATION; THROMBOCYTE ACTIVATION;

EID: 0030783293     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13:501-6.
2. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346:425-34.
3. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67:1033-6.
4. Canonica GW, Ciprandi C, Buscaglia S, Pesce G, Bagnasco M. Adhesion molecules of allergic inflammation: recent insights into their functional roles. Allergy 1994; 49:135-41.
5. Bousquet, J, Chanez P Chanez JY et al. Eosinophilic inflammation in asthma. New Engl J Med 1990; 323:1033.
6. Naclerio RM, Proud D, Togias AG et al. Inflammatory mediators in late antigen-induced rhinitis. N Eng J Med 1985; 313:65-70.
7. Bonini SE, Bonini ST, Bucci MG et al. Allergen dose response and late symptoms in human model of occular allergy. J Allergy Clin Immunol 1990; 86:869-76.
8. Proud D, Sweet J, Stein P et al. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 1990; 85:896-905.
9. Montefort S, Herbert CA, Robinson C, Holgate ST. The bronchial epithelium as a target for inflammatory attack in asthma. Clin Exp Allergy 1992; 22:511-20.
10. Dustin M, Rothlein R, Bhan AK, Dinarello, CA, Springer TA. Induction by IL-1 and interferon-gamma: Tissue distribution, biochemistry and function of natural adherence molecule (ICAM-1). J Immunol 1986; 137:245-54.
11. Wegner CD, Gundel RH, Reilly P et al. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 247:456-9.
12. Tosi MF, Stark JM, Smith CW et al. Induction of ICAM-1 expression on human epithelial cells by inflammatory cytokines:effects on neutrophil-epithelial cell adhesion. Am J Respr Cell Mol Biol 1992; 7:214-21.
13. Altman LC, Ayars GH, Baker C, Luchtel DL. Cytokines and eosinophil-derived cationic proteins upregulate intercellular adhesion molecule-1 on human nasal epithelial cells. J Allergy Clin Immunol 1993; 92:527-36.
14. Bentley AM, Durham SR, Robinson DS et al. Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin and vascular cell adhesion molecule-1 in the bronchial mucosa in steady state and allergen-induced asthma. J Allergy Clin Immunol 1993; 92:857-68.
15. Vignola AM, Campbell AM, Chanez P et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Resp Dis 1993; 148:689-94.
16. Montefort S, Roche WR, Howard PH et al. Intercellular adhesion molecule-1 (ICAM-1) and endothelial leukocyte adhesion molecule-1 (ELAM-1) expression in the bronchial mucosa of normal and asthmatic subjects. Eur Resp J 1992; 5:815-23.
17. Pesce GP, Fiorino N, Buscaglia S et al. In situ hybridisation analysis of ICAM-1 (CD54) expression on conjunctival epithelium during allergic inflammation. ACI news 1994; Suppl 2:13.
18. Ciprandi C, Buscaglia S, Pesce G et al. Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 1993; 91:783-92.
19. Vignola AM, Crampette L, Mondain M et al. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy 1995; 50:200-3.
20. Ciprandi G, Buscaglia S, Pesce GP, Bagnasco M, Canonica GW. Ocular challenge and hyperresponsiveness to histamine in patients with allergic conjunctivitis. J Allergy Clin Immunol 1993; 91:1227-30.
21. Spencer CM, Faulds D, Peters DH. Cetirizine: A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993; 46:1055-80.
22. Ciprandi G, Buscaglia S, Pesce G et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995; 95:612-21.
23. Buscaglia S, Paolieri F, Catrullo A et al. Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro. Clin Exp Allergy 1996; 26:1188-96.
24. Ciprandi G, Buscaglia S, Pronzato C et al. Oxatomide reduces inflammatory events induced by allergen-specific conjunctival challenge. Ann Allergy 1995; 75:446-52.
25. Ciprandi G, Buscaglia S, Marchesi E et al. Protective effect of loratadine on late phase reaction induced by conjunctival provocation test. Int Arch Allergy Appl Immunol 1992; 907:1-5.
26. Ciprandi G, Buscaglia S, Iudice A, Canonica GW. Protective effect of terfenadine at different dosage on conjunctival provocation test. Allergy 1992; 47:309-12.
27. Ciprandi G, Pronzato C, Ricca V, Bagnasco M, Canonica GW. Evidence of intracellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure. J Allergy Clin Immunol 1994; 99:738-46.
28. Ciprandi G, Buscaglia S, Pesce GP et al. Effects of conjuctival hyperosmolar challenge in allergic subjects and normal controls. Int Arch Allergy Immunol 1994; 104:92-6.
29. Djukanovic R, Roche WR, Wilson JW et al. Mucosal inflammation in asthma. Am Rev Resp Dis 1990; 142:434-57.
30. Jeffrey PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. Am Rev Resp Dis 1989; 140:1745-53.
31. Ciprandi G, Buscaglia S, Pesce BS et al. Minimal persistent inflammmation is present at mucosal level in patients with asymptomatic rhinits and mite allergy. J Allergy Clin Immunol 1995; 96:971-9.
32. Staunton DE, Merluzzi VJ, Rothlein R et al. A cell adhesion molecule ICAM-1 is the major surface receptor for rhinovirusues. Cell 1989; 56:849.
33. Bardin PK, Johnston SL, Pattemore PK. Viruses as precipitants of asthma symptoms. II. physiology and mechanisms. Clin Exp Allergy 1992; 22:809-22.
34. Pattemore PK, Johnston SL, Bardin PK. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy 1992; 22:325-36.
35. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Brit Med J 1995; 310:1223-9.
36. Canonica GW, Ciprandi G, Pesce GP et al. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 1995; 107:99-102.
37. Eggleston PA. Upper airway inflammatory diseases and bronchial hyperresponsiveness. J Allergy Clin Immunol 1988; 81:1036-41.
38. Fasce L, Ciprandi G, Pronzato C et al. Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persitent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 1996; 109:272-6.
39. Ciprandi G, Pronzato C, Ricca V et al. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy. Clin Exp Allergy 1995; 25:871-8.
40. Tosca M, Ricca V, Carosso A et al. Cetirizine treatment of allergic cough in children with pollinosis. Allergy 1996; 51/31 Suppl. Abs WS 112.
41. Pretolani MC, Ruffie C, de Silva L et al. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med 1994; 180:795.
42. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwanoto I. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994; 179:1145.
43. Petezelbauer P, Stingl G, Wolff K, Volc-Platzer B. Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol 1991; 96:362-9.
44. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissman G. A mechanism for the anti-inflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of ELAM-1 and ICAM-1. Proc Natl Acad Sci USA 1992; 89:45-56.
45. Ciprandi G, Buscaglia S, Pesce GP et al. Deflazacort protects late-phase, but not early phase events induced by allergen specific conjunctival provocation test. Allergy 1993; 48:421-30.
46. Caproni M, Giovannii MP, Falcos D. Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesions. Int J Dermatol 1995; 34:510-3.
47. Kyan-Aung U, Hallsworth M, Haskard D, De Vos C, Lee T. The effects of cetirizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells. J Allergy Clin Immunol 1992; 90:270-2.
48. Walsh GM, Moqbel R, Hartnell A, Kay AB. Effects of cetirizine on human eosinophil and neutrophil activation in vitro. Int Arch Allergy Appl Immunol 1991; 95:158-62.
49. Fadel R, Herpin-Richard N, Rihoux J-P. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 1987; 7:373-9.
50. Sehmi R, Walsh GM, Hartnell A et al. Modulation of human eosinophil chemotaxis and adhesion by anti-allergic drugs in vitro. Fed Allergy Immunol 1993; 4 (suppl. 4):13-8.